Ebstein Anomaly Clinical Trial
Official title:
Fetal Ebstein Anomaly and Tricuspid Valve Dysplasia Registry
Ebstein anomaly and tricuspid valve dysplasia (EA/TVD) are rare congenital tricuspid valve malformations that carry among the highest mortality of all congenital heart disease diagnosed in utero. Despite the high mortality associated with severe EA/TVD in the fetus, it has only been studied retrospectively. By prospectively enrolling a cohort across multiple centers, many questions may be answered in the perinatal period and beyond. The registry will allow us to understand perinatal and postnatal decision-making in this complex group of patients across centers.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02914171 -
Study of Autologous Bone Marrow Derived Mononuclear Cells for Treatment of Ebstein Anomaly
|
Phase 1 | |
| Completed |
NCT01907971 -
Assessment of Left and Right Ventricular Function in Patients With Ebstein Anomaly With Different Echocardiographic Methods
|
N/A |